INT MEDICAL (01501) announced that the company has submitted a filing to the China Securities Regulatory Commission (CSRC) for the implementation of full circulation of its H shares. According to the CSRC filing, the company has applied on behalf of certain shareholders to convert a total of 71.7866 million domestic shares held by these shareholders into H shares and list them on the Hong Kong Stock Exchange (HKEX).
Upon obtaining all necessary filings and/or approvals from relevant regulatory authorities, including the CSRC and HKEX, and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and listed for trading on the Main Board of HKEX.
In accordance with the company's articles of association, no shareholders' meeting is required to approve the conversion and listing.